Evidence map›Paper›PMID 38739279›Full record

ArticleMikrochimica acta2024

Development of a time-resolved immunochromatographic test strip for rapid and quantitative determination of GFAP in serum.

Yupeng Wang, Zhiyong Yu, Zhenqiu Ning, Minghui Li, Weiping Li, Yizhe Zhong, Huiqiang Chen, Xi Zhang, Xialin Tang, Xiao Cheng and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yupeng Wang *School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, Guangdong, China. 1954920354@qq.com.ORCID http://orcid.org/0009-0008-8010-2168
Zhiyong Yu *School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, Guangdong, China.
Zhenqiu Ning *The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Minghui LiSchool of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, Guangdong, China.
Weiping LiSchool of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, Guangdong, China.
Yizhe ZhongSchool of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, Guangdong, China.
Huiqiang ChenSchool of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, Guangdong, China.
Xi ZhangThe Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, SAR, China.
Xialin TangDepartment of Neurology, Hubei Provincial Hospital of Traditional Chinese Medicine, Affiliated Hospital of Hubei University of Traditional Chinese Medicine, Wuhan, Hubei, China.
Xiao ChengThe Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Laiqing LiChina-Uzbekistan Institute of Biomedical Industry Technology, Guangzhou, Guangdong, China.
Abduldayeva AigulResearch Institute of Preventive Medicine named Academician E. Dalenov, Astana Medical University, Astana, Kazakhstan.
Jie ZanSchool of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, Guangdong, China. zanj@gdut.edu.cn.

Funding

Administration of Traditional Chinese Medicine of Hubei Province for Youths, China ZY2023Q001Natural Science Foundation of Hubei Province for Youths, China 2022CFB923Science and Technology Commissioner Project of Guangdong Province GDKTP2021003800Science and Technology Planning Project of Guangdong Province 2023B1212060062Science and Technology Planning Project of Guangzhou 202201011643
6 · The paper itself

Abstract

Glial fibrillary acidic protein (GFAP) in serum has been shown as a biomarker of traumatic brain injury (TBI) which is a significant global public health concern. Accurate and rapid detection of serum GFAP is critical for TBI diagnosis. In this study, a time-resolved fluorescence immunochromatographic test strip (TRFIS) was proposed for the quantitative detection of serum GFAP. This TRFIS possessed excellent linearity ranging from 0.05 to 2.5 ng/mL for the detection of serum GFAP and displayed good linearity (Y = 598723X + 797198, R

Indexed as

Chromatography, AffinityGlial Fibrillary Acidic ProteinBiomarkersCerebral HemorrhageHumansLimit of DetectionReagent StripsBiomarkersGFAP protein, humanGlial Fibrillary Acidic ProteinReagent StripsFluorescence test stripGlial fibrillary acidic proteinTraumatic brain injury

Identifiers

PMID38739279

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.